July 31 (Reuters) - Cannabis company Cresco Labs said on Monday it has terminated the $2 billion deal to buy rival Columbia Care Inc. (Reporting by Arshreet Singh in Bengaluru; Editing by Krishna Chandra Eluri)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.22 CAD | -5.13% | -7.50% | +24.02% |
05-16 | Cresco Labs Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-15 | Transcript : Cresco Labs Inc., Q1 2024 Earnings Call, May 15, 2024 |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
2,323 JPY | -0.68% | +1.88% | 306M | ||
2.22 CAD | -5.13% | -7.50% | 565M | ||
0.24 CAD | -5.88% | -17.24% | 82.73M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.02% | 565M | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B | |
-4.38% | 156B |
- Stock Market
- Equities
- CL Stock
- News Cresco Labs Inc.
- Cresco Labs terminates $2 bln deal to buy Columbia Care